These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical uses of naltrexone: a review of the evidence. Modesto-Lowe V, Van Kirk J. Exp Clin Psychopharmacol; 2002 Aug; 10(3):213-27. PubMed ID: 12233982 [Abstract] [Full Text] [Related]
7. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. O'Brien CP. Am J Psychiatry; 2005 Aug; 162(8):1423-31. PubMed ID: 16055763 [Abstract] [Full Text] [Related]
8. New horizons for therapeutics in drug and alcohol abuse. Jupp B, Lawrence AJ. Pharmacol Ther; 2010 Jan; 125(1):138-68. PubMed ID: 19917308 [Abstract] [Full Text] [Related]
9. Pharmacologic management of relapse prevention in addictive disorders. Sofuoglu M, Kosten TR. Psychiatr Clin North Am; 2004 Dec; 27(4):627-48. PubMed ID: 15550284 [Abstract] [Full Text] [Related]
10. Addiction pharmacotherapy 2000: new options, new challenges. Rawson RA, McCann MJ, Hasson AJ, Ling W. J Psychoactive Drugs; 2000 Dec; 32(4):371-8. PubMed ID: 11210198 [Abstract] [Full Text] [Related]
11. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders. McCann DJ. Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797 [Abstract] [Full Text] [Related]
12. Pharmacotherapy for Substance Use Disorders. Klein JW. Med Clin North Am; 2016 Jul; 100(4):891-910. PubMed ID: 27235620 [Abstract] [Full Text] [Related]
13. Pharmacogenetic treatments for drug addiction: alcohol and opiates. Haile CN, Kosten TA, Kosten TR. Am J Drug Alcohol Abuse; 2008 Jul; 34(4):355-81. PubMed ID: 18584566 [Abstract] [Full Text] [Related]
14. Naltrexone in patients with bipolar disorder and alcohol dependence. Brown ES, Beard L, Dobbs L, Rush AJ. Depress Anxiety; 2006 Jul; 23(8):492-5. PubMed ID: 16841344 [Abstract] [Full Text] [Related]
15. Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002. Colker AC. Issue Brief Health Policy Track Serv; 2002 Dec 31; ():1-6. PubMed ID: 12875273 [No Abstract] [Full Text] [Related]
16. Medications for substance use disorders. Douaihy AB, Kelly TM, Sullivan C. Soc Work Public Health; 2013 Dec 31; 28(3-4):264-78. PubMed ID: 23731419 [Abstract] [Full Text] [Related]
17. Alcohol abuse and alcoholism: an overview. Volpicelli JR. J Clin Psychiatry; 2001 Dec 31; 62 Suppl 20():4-10. PubMed ID: 11584874 [Abstract] [Full Text] [Related]
18. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. van den Brink W. Curr Drug Abuse Rev; 2012 Mar 31; 5(1):3-31. PubMed ID: 22126708 [Abstract] [Full Text] [Related]
19. The role of the endogenous cannabinoid system in drug addiction. Parolaro D, Rubino T. Drug News Perspect; 2008 Apr 31; 21(3):149-57. PubMed ID: 18560613 [Abstract] [Full Text] [Related]
20. [Naltrexone in the therapeutic relation in cases of opioid abuse and dependence]. Liffredo C, Gallino G. Minerva Med; 1993 Dec 31; 84(12):687-92. PubMed ID: 8127459 [Abstract] [Full Text] [Related] Page: [Next] [New Search]